Failure to Monitor Anticoagulant and Antidepressant Use
Summary
The facility failed to appropriately monitor the drug regimens of two residents, leading to potential complications. Resident 6, who was readmitted with diagnoses including atrial fibrillation and transient ischemic attack, was prescribed Eliquis, an anticoagulant. Despite a care plan indicating the need for monitoring for signs of bleeding, there was no documented evidence of such monitoring in the medication administration records. The MDS Nurse confirmed that the order for monitoring was not carried over upon readmission, and the Director of Nursing acknowledged that the staff should have documented monitoring for bleeding and bruising. Resident 164, admitted with major depressive disorder and atrial fibrillation, was prescribed Apixaban, another anticoagulant, and antidepressants Mirtazapine and Escitalopram. The facility's protocol required monitoring for signs of bleeding, but there was no order for such monitoring, and consequently, no documentation on the MAR. The Registered Nurse Supervisor noted that monitoring for bleeding should have been automatically ordered with the anticoagulant prescription. Additionally, there was a lack of monitoring for the effectiveness and side effects of the antidepressants, which was necessary to adjust dosing appropriately. The facility's policies and procedures for anticoagulation and antipsychotic medication use were not followed, as evidenced by the lack of monitoring and documentation for both residents. The Director of Nursing confirmed the necessity of monitoring and documenting findings for residents on anticoagulants and antidepressants to prevent unnoticed bleeding and ensure appropriate medication adjustments.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.